Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Hypoxia Inducible Factor 1 Alpha Inhibitor by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Hypoxia Inducible Factor 1 Alpha Inhibitor by Country/Region, 2017, 2022 & 2028

2.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment by Type

2.2.1 BC-001

2.2.2 CASI-2ME2

2.2.3 CRLX-101

2.2.4 Others

2.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type

2.3.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2017-2022)

2.3.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Market Share by Type (2017-2022)

2.3.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sale Price by Type (2017-2022)

2.4 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment by Application

2.4.1 Solid Tumor

2.4.2 Acute Myelocytic Leukemia

2.4.3 Colorectal Cancer

2.4.4 Others

2.5 Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application

2.5.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sale Market Share by Application (2017-2022)

2.5.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue and Market Share by Application (2017-2022)

2.5.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sale Price by Application (2017-2022)

3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor by Company

3.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Breakdown Data by Company

3.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Annual Sales by Company (2020-2022)

3.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Company (2020-2022)

3.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Annual Revenue by Company (2020-2022)

3.2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Company (2020-2022)

3.2.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Company (2020-2022)

3.3 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sale Price by Company

3.4 Key Manufacturers Hypoxia Inducible Factor 1 Alpha Inhibitor Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Hypoxia Inducible Factor 1 Alpha Inhibitor Product Location Distribution

3.4.2 Players Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Hypoxia Inducible Factor 1 Alpha Inhibitor by Geographic Region

4.1 World Historic Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size by Geographic Region (2017-2022)

4.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Annual Revenue by Geographic Region

4.2 World Historic Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size by Country/Region (2017-2022)

4.2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Annual Sales by Country/Region (2017-2022)

4.2.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Annual Revenue by Country/Region

4.3 Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth

4.4 APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth

4.5 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth

4.6 Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth

5 Americas

5.1 Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country

5.1.1 Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2017-2022)

5.1.2 Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2017-2022)

5.2 Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type

5.3 Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Region

6.1.1 APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Region (2017-2022)

6.1.2 APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Region (2017-2022)

6.2 APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type

6.3 APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor by Country

7.1.1 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2017-2022)

7.1.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2017-2022)

7.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type

7.3 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor by Country

8.1.1 Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2017-2022)

8.1.2 Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2017-2022)

8.2 Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type

8.3 Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor

10.3 Manufacturing Process Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor

10.4 Industry Chain Structure of Hypoxia Inducible Factor 1 Alpha Inhibitor

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Distributors

11.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Customer

12 World Forecast Review for Hypoxia Inducible Factor 1 Alpha Inhibitor by Geographic Region

12.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size Forecast by Region

12.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast by Region (2023-2028)

12.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast by Type

12.7 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast by Application

13 Key Players Analysis

13.1 Aileron Therapeutics, Inc.

13.1.1 Aileron Therapeutics, Inc. Company Information

13.1.2 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

13.1.3 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Aileron Therapeutics, Inc. Main Business Overview

13.1.5 Aileron Therapeutics, Inc. Latest Developments

13.2 CASI Pharmaceuticals Inc.

13.2.1 CASI Pharmaceuticals Inc. Company Information

13.2.2 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

13.2.3 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CASI Pharmaceuticals Inc. Main Business Overview

13.2.5 CASI Pharmaceuticals Inc. Latest Developments

13.3 Cerulean Pharma, Inc.

13.3.1 Cerulean Pharma, Inc. Company Information

13.3.2 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

13.3.3 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Cerulean Pharma, Inc. Main Business Overview

13.3.5 Cerulean Pharma, Inc. Latest Developments

13.4 F. Hoffmann-La Roche Ltd.

13.4.1 F. Hoffmann-La Roche Ltd. Company Information

13.4.2 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

13.4.3 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 F. Hoffmann-La Roche Ltd. Main Business Overview

13.4.5 F. Hoffmann-La Roche Ltd. Latest Developments

13.5 InterMed Discovery GmbH

13.5.1 InterMed Discovery GmbH Company Information

13.5.2 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

13.5.3 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 InterMed Discovery GmbH Main Business Overview

13.5.5 InterMed Discovery GmbH Latest Developments

13.6 OncoImmune, Inc.

13.6.1 OncoImmune, Inc. Company Information

13.6.2 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

13.6.3 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 OncoImmune, Inc. Main Business Overview

13.6.5 OncoImmune, Inc. Latest Developments

13.7 Peloton Therapeutics, Inc.

13.7.1 Peloton Therapeutics, Inc. Company Information

13.7.2 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

13.7.3 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Peloton Therapeutics, Inc. Main Business Overview

13.7.5 Peloton Therapeutics, Inc. Latest Developments

13.8 RXi Pharmaceuticals Corporation

13.8.1 RXi Pharmaceuticals Corporation Company Information

13.8.2 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

13.8.3 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 RXi Pharmaceuticals Corporation Main Business Overview

13.8.5 RXi Pharmaceuticals Corporation Latest Developments

13.9 Sorrento Therapeutics, Inc.

13.9.1 Sorrento Therapeutics, Inc. Company Information

13.9.2 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

13.9.3 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sorrento Therapeutics, Inc. Main Business Overview

13.9.5 Sorrento Therapeutics, Inc. Latest Developments

13.10 Transcriptogen Ltd

13.10.1 Transcriptogen Ltd Company Information

13.10.2 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

13.10.3 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Transcriptogen Ltd Main Business Overview

13.10.5 Transcriptogen Ltd Latest Developments

13.11 Vascular Biogenics Ltd.

13.11.1 Vascular Biogenics Ltd. Company Information

13.11.2 Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

13.11.3 Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Vascular Biogenics Ltd. Main Business Overview

13.11.5 Vascular Biogenics Ltd. Latest Developments

14 Research Findings and Conclusion

Table 1. Hypoxia Inducible Factor 1 Alpha Inhibitor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Hypoxia Inducible Factor 1 Alpha Inhibitor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of BC-001

Table 4. Major Players of CASI-2ME2

Table 5. Major Players of CRLX-101

Table 6. Major Players of Others

Table 7. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2017-2022)

Table 9. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Type (2017-2022) & ($ million)

Table 10. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Type (2017-2022)

Table 11. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2017-2022)

Table 14. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Application (2017-2022)

Table 15. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Application (2017-2022)

Table 16. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Company (2020-2022)

Table 19. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Company (2020-2022)

Table 21. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Hypoxia Inducible Factor 1 Alpha Inhibitor Producing Area Distribution and Sales Area

Table 23. Players Hypoxia Inducible Factor 1 Alpha Inhibitor Products Offered

Table 24. Hypoxia Inducible Factor 1 Alpha Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share Geographic Region (2017-2022)

Table 29. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country/Region (2017-2022)

Table 33. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country (2017-2022)

Table 37. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country (2017-2022)

Table 39. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2017-2022)

Table 41. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2017-2022)

Table 43. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Region (2017-2022)

Table 45. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Region (2017-2022)

Table 47. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2017-2022)

Table 49. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2017-2022)

Table 51. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country (2017-2022)

Table 53. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country (2017-2022)

Table 55. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2017-2022)

Table 57. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Hypoxia Inducible Factor 1 Alpha Inhibitor

Table 68. Key Market Challenges & Risks of Hypoxia Inducible Factor 1 Alpha Inhibitor

Table 69. Key Industry Trends of Hypoxia Inducible Factor 1 Alpha Inhibitor

Table 70. Hypoxia Inducible Factor 1 Alpha Inhibitor Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Hypoxia Inducible Factor 1 Alpha Inhibitor Distributors List

Table 73. Hypoxia Inducible Factor 1 Alpha Inhibitor Customer List

Table 74. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Forecast by Region

Table 76. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share Forecast by Application (2023-2028)

Table 94. Aileron Therapeutics, Inc. Basic Information, Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 95. Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

Table 96. Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Aileron Therapeutics, Inc. Main Business

Table 98. Aileron Therapeutics, Inc. Latest Developments

Table 99. CASI Pharmaceuticals Inc. Basic Information, Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 100. CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

Table 101. CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. CASI Pharmaceuticals Inc. Main Business

Table 103. CASI Pharmaceuticals Inc. Latest Developments

Table 104. Cerulean Pharma, Inc. Basic Information, Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 105. Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

Table 106. Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Cerulean Pharma, Inc. Main Business

Table 108. Cerulean Pharma, Inc. Latest Developments

Table 109. F. Hoffmann-La Roche Ltd. Basic Information, Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 110. F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

Table 111. F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. F. Hoffmann-La Roche Ltd. Main Business

Table 113. F. Hoffmann-La Roche Ltd. Latest Developments

Table 114. InterMed Discovery GmbH Basic Information, Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 115. InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

Table 116. InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. InterMed Discovery GmbH Main Business

Table 118. InterMed Discovery GmbH Latest Developments

Table 119. OncoImmune, Inc. Basic Information, Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 120. OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

Table 121. OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. OncoImmune, Inc. Main Business

Table 123. OncoImmune, Inc. Latest Developments

Table 124. Peloton Therapeutics, Inc. Basic Information, Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 125. Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

Table 126. Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. Peloton Therapeutics, Inc. Main Business

Table 128. Peloton Therapeutics, Inc. Latest Developments

Table 129. RXi Pharmaceuticals Corporation Basic Information, Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 130. RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

Table 131. RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. RXi Pharmaceuticals Corporation Main Business

Table 133. RXi Pharmaceuticals Corporation Latest Developments

Table 134. Sorrento Therapeutics, Inc. Basic Information, Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 135. Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

Table 136. Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 137. Sorrento Therapeutics, Inc. Main Business

Table 138. Sorrento Therapeutics, Inc. Latest Developments

Table 139. Transcriptogen Ltd Basic Information, Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 140. Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

Table 141. Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 142. Transcriptogen Ltd Main Business

Table 143. Transcriptogen Ltd Latest Developments

Table 144. Vascular Biogenics Ltd. Basic Information, Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Base, Sales Area and Its Competitors

Table 145. Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Product Offered

Table 146. Vascular Biogenics Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 147. Vascular Biogenics Ltd. Main Business

Table 148. Vascular Biogenics Ltd. Latest Developments

List of Figures

Figure 1. Picture of Hypoxia Inducible Factor 1 Alpha Inhibitor

Figure 2. Hypoxia Inducible Factor 1 Alpha Inhibitor Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Hypoxia Inducible Factor 1 Alpha Inhibitor Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of BC-001

Figure 10. Product Picture of CASI-2ME2

Figure 11. Product Picture of CRLX-101

Figure 12. Product Picture of Others

Figure 13. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Type in 2021

Figure 14. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Type (2017-2022)

Figure 15. Hypoxia Inducible Factor 1 Alpha Inhibitor Consumed in Solid Tumor

Figure 16. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market: Solid Tumor (2017-2022) & (K Pcs)

Figure 17. Hypoxia Inducible Factor 1 Alpha Inhibitor Consumed in Acute Myelocytic Leukemia

Figure 18. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market: Acute Myelocytic Leukemia (2017-2022) & (K Pcs)

Figure 19. Hypoxia Inducible Factor 1 Alpha Inhibitor Consumed in Colorectal Cancer

Figure 20. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market: Colorectal Cancer (2017-2022) & (K Pcs)

Figure 21. Hypoxia Inducible Factor 1 Alpha Inhibitor Consumed in Others

Figure 22. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market: Others (2017-2022) & (K Pcs)

Figure 23. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Application (2017-2022)

Figure 24. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Application in 2021

Figure 25. Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Company in 2021

Figure 27. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Geographic Region in 2021

Figure 29. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Region (2017-2022)

Figure 30. Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country/Region in 2021

Figure 31. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales 2017-2022 (K Pcs)

Figure 32. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue 2017-2022 ($ Millions)

Figure 33. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales 2017-2022 (K Pcs)

Figure 34. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue 2017-2022 ($ Millions)

Figure 35. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales 2017-2022 (K Pcs)

Figure 36. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue 2017-2022 ($ Millions)

Figure 39. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country in 2021

Figure 40. Americas Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country in 2021

Figure 41. United States Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Region in 2021

Figure 46. APAC Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Regions in 2021

Figure 47. China Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country in 2021

Figure 54. Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country in 2021

Figure 55. Germany Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Market Share by Country in 2021

Figure 62. Egypt Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor in 2021

Figure 68. Manufacturing Process Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor

Figure 69. Industry Chain Structure of Hypoxia Inducible Factor 1 Alpha Inhibitor

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles